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Abstract
Metabolic syndrome is a constellation of risk factors that has the potential of developing into cardio-
vascular disease or increase the susceptibility to it. It is present worldwide with now even developing 
countries getting overwhelmed by its burden. With a shift towards unhealthy diet coupled with se-
dentary lifestyle, development of metabolic syndrome is on the rise even among young adults. One 
of the main causes of this problem is faulty diet, so any means to reduce the incidence of the syn-
drome involves the modification of the existing diets rich in saturated fat, sodium and cholesterol. 
This review focusses on efficacy of different dietary patterns for combating the syndrome along with 
other lifestyle risk factors. It also highlights newer advancements in the field of Metabolic Syndro-
me, which can serve as potential strategies to combat it. Public health interventions targeting adults, 
therefore, should center on prevention through education, modification of diet and lifestyle, and 
focusing on environment, so that these changes are acceptable and sustainable.
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Introduction
Metabolic syndrome (MetS) is a complicated disorder that increases a person’s risk to cardiovascular 
diseases (CVD) and diabetes (DM). It is a cluster of interrelated factors characterized by high fasting 
blood glucose, increased level of triglycerides, low levels of high density cholesterol (HDL), elevated 
blood pressure and abdominal obesity [1]. However, defining MetS is a complicated task as there is no 
one universal definition. With its increasing prevalence in childhood and adulthood, it poses immense 
future implications on the global burden of disease relating to obesity and sedentary lifestyle. MetS thus 
can be viewed from both a public health as well as a clinical perspective. While in the public health 
arena it focuses on modification of lifestyle, at clinical level, it confluences on diagnosis of risk factors 
related to MetS including lifestyle related factors. Despite there being a disagreement on the consensus 
of one universal definition, there appears to be an agreement that MetS poses risk for developing CVD 
and DM [2,3]. Though MetS is not an absolute risk factor, it presents a impressive risk of developing 
CVD in future [4,5]. The concept of ‘Syndrome X’ which was renamed as MetS later, was pioneered by 
Reaven [6], estimating it as an importante factor in the development of CVD and DM. He identified 
insulin resistance and subsequent hyperinsulinemia as the indispensable underlying risk factors for 
hypertension, hyperlipidemia, diabetes and eventually CVD. Although, he did not acknowledge obesi-
ty as caused by insulin resistance, he did acknowledge its correlation with Syndrome X or MetS. It was 
inferred then that weight maintenance and physical activity were the pivotal elements for the treatment 
[7]. The beginning of defining MetS began in 1998, by a consultation group on the definition of diabe-
tes for the World Health Organization (WHO) [8]. This was followed by the European Group for the 
study of Insulin Resistance (EGIR) [9] in 1999, the National Cholesterol Education Program Adult 
Treatment Panel III (NCEP:ATPIII) [10] in 2001, the American Association of Clinical Endocrinology 
(AACE) [11] in 2003, the International Diabetes Federation (IDF) [12], and the American Heart Asso-
ciation/National Heart, Lung, and Blood Institute (AHA/NHLBI) [13] in 2005.The criteria for defining 
MetS vary among all these definitions (Table I).
Another pertinent aspect relating to the MetS is the applicability of the above defined criteria in relation to 
various ethnic groups. Ethnicity poses an important question for diagnosis of MetS. Due to mixed ethnici-
ty in the world, it is important to be pragmatic with this aspect. A primary perspective lies in the fact that 
a common definition to diagnose MetS must be used worldwide, keeping into consideration the difference 
between sexes and ethnic groups. The different proposed definitions of MetS have varied applicability 
across various ethnicities. The dilemma arises in the case of defining obesity cut offs as type 2 DM is at 
lower levels of obesity in Asians in contrast to Europeans. Solution to this dilemma has been recognized by 
IDF that has supported new ethnic cutoffs to diagnose MetS. However, it is imperative to possess one de-
finition that is applicable worldwide, keeping in view the amplifying epidemic of CVD and type 2 DM [4].
Regardless of the varying criteria proposed by different definitions, the prevalence of MetS is on the 
rise in both western and Asian countries [14-16]. Increment in the proportion of diagnosed individuals 
can be related to increase in age and BMI [17]. Not only the western societies, but also the developing 
countries are now getting overwhelmed in the burden of this problem. This rise can be attributed to 
the transition in the lifestyle from a traditional to a western one. The genesis of MetS and obesity in 
developing countries relates to demographic transition (shift to low fertility, low mortality, and higher 
life expectancy), and epidemiological transition (from widely prevalent infectious diseases to a pattern 
of a high prevalence of lifestyle related diseases) congregating genetics and environment [5,18-20].
The double burden of under and over nutrition in the developing countries is leading to the increa-
sed risk for CVD and sequential morbidity and mortality. Health interventions focusing on favorable 
dietary and lifestyle practices are the need of the hour in developing countries simultaneous with the 
adequate support of government and legislative bodies. Therefore, this review was undertaken to assess 
the current dietary patterns and newer advancements effective in combating MetS.
Expert group/ 
organization
Diagnostic criteria
Glycemia Obesity Dyslipidemia BP Any other
World Health 
Organization 
(WHO), 1998
>100 mg/dl WHR:
men>0.9, 
women>0.85; 
BMI>30 kg/m2
TG:150 mg/dl or greater 
and/or
HDL-C: men<40 mg/dl, 
women<50 mg/dl
140/90 mmHg 
or greater
Microalbuminuria
20 μg/min or 
greater
30 mg/g or greater
Insulin resistance plus two of the above
European Group for 
the Study of Insulin 
Resistance (EGIR), 
1999
110 mg/dl 
or greater
WC: men 94 cm or 
greater,
women 80 cm or 
greater
TG: 150 mg/dl or greater 
and/or
HDL-C: <39 mg/dl in 
men or women
140/90 mmHg 
or greater
Insulin resistance plus two of the above
National Cholesterol 
Education 
Program Adult 
Treatment Panel III 
(NCEP:ATPIII) 2001
110 mg/dl 
or greater
WC: men>102 cm, 
women>88 cm
TG: 150 mg/dl or greater, 
HDL-C: men<40 mg/dl,
women<50 mg/dl
130/85 mmHg 
or greater
Any three or more of the above
American 
Association 
of Clinical 
Endocrinology 
(AACE), 2003
Impaired 
Glucose 
Tolerance
BMI: 25 kg/m2 or 
greater
TG: 150 mg/dl or greater 
and/or HDL-C: men<40 
mg/dl, women<50 mg/dl
130/85 mmHg 
or greater
IGT plus two or more of the above
American Heart 
Association/National 
Heart, Lung, and 
Blood Institute 
(AHA/NHLBI), 2005
100 mg/dl 
or greater
WC: men 102 cm or 
greater,
women 88 cm or 
greater
TG: 150 mg/dl or greater; 
HDL-C: men< 0 mg/dl,
women<50 mg/dl
130/85 mmHg 
or greater
Any three of the above
International 
Diabetes Federation 
(IDF), 2005
100 mg/dl 
or greater
BMI>30 kg/m2 TG: 150 mg/dl or greater; 
HDL-C: men<40 mg/dl, 
women<50 mg/ dl
130/85 mmHg 
or greater
Central obesity plus two of the above
Consensus definition 
(incorporating IDF 
and AHA/NHLBI
definitions), 2005
100 mg/dl 
or greater
Elevated WC 
(according to 
population and 
country-specific 
definitions)*
TG: 150 mg/dl or greater; 
HDL-C: men<40 mg/dl, 
women<50 mg/dl
130/85 mmHg 
or greater
Any three of the above
Table I. Differential criteria proposed by various expert groups to define Metabolic Syndrome
* Waist circumference: for Europeans, > 94 cm in men and > 80 cm in women; and for South Asians, Chinese, 
and Japanese, > 90 cm in men and > 80 cm in women. For ethnic South and Central Americans, South Asian 
data are used, and for sub-Saharan Africans and Eastern Mediterranean and Middle East (Arab) populations, 
European data are used.
BMI = Body Mass Index; BP = Blood Pressure; IFG = Impaired fasting glucose; HDL- C = High Density 
Lipoprotein-Cholesterol; TG = Triglycerides; WC = Waist circumference ; WHR = Waist Hip ratio
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This current review focusses on efficacy of various existing dietary patterns for combating the syndro-
me along with other lifestyle risk factors. It also highlights newer advancements in the field of Metabo-
lic Syndrome, which can serve as potential strategies to combat it.
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Methodology
In this article, we have reviewed existing literature regarding the current prevalence of MetS with focus 
on its relationship with diet as the most important modifiable factor. Besides this, relationship with 
other lifestyle factors and newer advancements to combat MetS has also been looked upon. Literature 
search was carried out using PubMed (National Library of Medicine, Bethesda, MD, USA), Medline, 
Cochrane Library, Science Direct, and Google Scholar databases. The keywords used were Metabo-
lic Syndrome, diet, lifestyle, oxidative stress, gut microbiota, non-communicable diseases, prevalence, 
adults, inflammation and genetics. Published studies which have been listed in the above mentioned 
databases have been included in this review.
Prevalence patterns of MetS in the developing world
The prevalence of MetS is on the rise across the world. Twenty five percent of new cases of CVD are 
accounted by MetS. However according to the Framingham study in absence of DM, the risk of CVD 
is not increased by more than 20% (less than 10% for females, and between 10-20% for males) [21]. 
Variation in prevalence occurs with respect to sex, age and ethnicity [22,23]. MetS is even affecting 
the developing countries such as India and China. In India, urban Indians are most susceptible to 
its development owing to affluence of middle class, urbanization, mechanization, marked changes in 
diet (increased consumption of “calorie-dense foods”) and sedentary habits [24], without overlooking 
the facet of rural Indian populations who are being affected by it as well [25-27]. This is an important 
matter, as without effective intervention strategies, it can lead to T2DM and CVD in future. Moreover, 
in comparison with Whites, South Asians exhibit CVD onset and diagnosis at a younger age [28]. The 
term “South Asian” refers to the “1.5 billion people belonging to the southern region of the Asian con-
tinent comprising the sub-Himalayan countries”. These countries include India, Pakistan, Nepal, Sri 
Lanka, Bangladesh, Bhutan, Maldives, and the British Indian Ocean Territory [29].
In case of South Asians, MetS affects the migrants where its prevalence is around 20-25% [30,31].
Specifically, in urban India, the prevalence of MetS was estimated by ICMR task force during 1992-94 
in a collaborative study, according to which it was 30% in urban areas of Delhi and 11% in rural Ha-
ryana using the ATPIII criteria. Prevalence of 30% in urban slum population of Delhi [5] and 41% in 
urban area of Chennai was reported among adults using modified ATPIII criteria [32]. The difference, 
though not completely, is characterized by usage of various definitions of MetS used and implies that 
prevalence across studies cannot be compared. These high prevalence rates in India especially among 
the urban population are of immediate concern, with cardiovascular prevention as its focal point.
A cross-sectional study of adults above the age of 18 years, conducted in the rural district of Wardha, 
Central India, delineated that MetS was significantly higher among females (7.6%) in comparison to 
males (2.9%) using the ATPIII guidelines for diagnosis. However, the prevalence notched up to 10.7% 
and 8.2% among males and females respectively when Asia Pacific guidelines modified for waist cir-
cumference were used [25]. MetS is also marked by gender differences owing to different cutoffs set 
for waist circumference and HDL values, hence, potentially significant for diagnosis and prevention 
[33,34]. Socio economic status has been shown to have association with the prevalence of MetS [35-
37]. Inverse relationship appears between MetS and socio economic status, more strongly for women in 
comparison to men in developed countries [36-40]. On the contrary, no association was seen with the 
overall prevalence of the metabolic syndrome and socio economic status in a subset of the participants 
(n=839) from the 1986 Jamaica Birth Cohort who were evaluated at ages 18-20 years. This absence 
of association was attributed to lack of statistical power [41]. However, in the developing countries, 
prevalence is marked by affluence. This difference across the countries is attributed to the available 
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income for expenditure. In the developed countries, inverse association is accredited to the availability 
of low-cost energy dense foods that lead to insulin resistance to those with limited income. Moreover 
in women, low household income results in likely unemployment, reduced physical activity and stress, 
thus, leading to the syndrome [36]. In contrast, among developing countries, rise in income is associa-
ted with increase in consumption of foods high in energy and fat, animal foods and processed foods 
[42]. This leads to a great potential of poor health and subsequent development of MetS.
Considering age as an important determinant of MetS, a study to assess the prevalence of MetS in Iran 
was conducted with randomly selected adults >20 years selected using stratified sampling [43]. The 
prevalence was 23.7%, being same in men and women. Significant age related increase was observed in 
both sexes ranging from 7.5% (20-29 year age group) to 44.7% (> 60 years of age). Other studies have 
also reported an increase in prevalence of the syndrome with age (Table II). Studies conducted in India 
using variable criteria to determine the MetS prevalence showed that in South Indian population, it 
was 25.8% using IDF as compared to 18.3% by ATPIII, in individuals > 20 years of age [44]. Dissimilar 
trends were observed in Bangalore, where it was higher using the ATPIII criteria (40.3%) as compared 
to IDF criteria (34.9%) [18]. Prevalence studies in the rest of the world using different criteria have also 
demonstrated varying results (Table II). Engaging in different types of jobs is another important factor 
that has an implication in the development of MetS. Studies providing evidence for MetS have deter-
mined prevalence rates among laborers (11.8%), office employees (9.3%), and managers (7.7%) [45].
Design Country Sample Salient Finding(s) Reference
Cross-sectional Korea N=21,796 (aged 30 years 
and above)
High prevalence was observed in housewives in 
women (men 41.3%, women 33.7%) and office 
workers in men (men 30%, women 9.8%) who 
were the reference group to other occupations.
[46]
Cross-sectional Korea N=3,288 (aged 19 years 
and above)
Prevalence of the syndrome among young female 
workers (<50 years) was high (OR=1.95) compared 
to non-manual workers.
[47]
Cross-sectional Korea N=9,726 Association between occupation and MetS was 
observed in men but not in women.
Risk of the syndrome was high in white collar 
workers compared to blue collar workers (OR=1.4).
[48]
Cross-sectional Iran N=429 male bus and truck 
drivers
Prevalence – ATPIII criteria: 35.9%.
Positive correlation between BMI, DM, HT and 
MetS (p<0.001).
No positive correlation between smoking and MetS 
(p<0.06).
[49]
Cross-sectional China N=3,953 adults aged 
20-88 years (2,429 
females, 1,524 males).
Prevalence – ATPIII criteria: men 13.0%, women 
15.3%, who were alcohol drinkers.
[50]
Cross-sectional China N=2,334 adults aged 60 to 
95 years (943 men, 1,391 
women)
Prevalence – ATPIII criteria: 30.5% (17.6% in men, 
39.2% in women), IDF criteria: 46.3% (34.8% in 
men, 54.1% in women).
Odds ratio for CVD, stroke and PAD are higher 
among those with MetS (irrespective of criterion).
[51]
Cross-sectional China N=16,342 subjects aged 
20-90 years (8,801 males, 
7,541 females)
Age-standardized prevalence of MetS was 13.2%.
Prevalence was more in males (15.7%) compared 
to females (10.2%).
[52]
Cross-sectional Korea, 
Japan
N=6,824 (aged 20-79 
years)
Prevalence – IDF criteria: men 13.5%, women 15%. [53]
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Design Country Sample Salient Finding(s) Reference
Cross-sectional India N=19,973 for 
Questionnaire survey; 
10,442 biochemical testing 
(Industrial population, 
aged 20-69 years)
Prevalence – ATPIII criteria: 26.6% (men 20.9%, 
women 36.3%); IDF criteria: 35.4% (men 29.4%, 
women 46.1%).
[54]
Cross-sectional Turkey N=15,468 adults Prevalence of MetS was 17.91%, being more in 
females than males.
Prevalence of the syndrome and related disorders 
are significantly different according to the 
geographical region.
[55]
Cross-sectional Korea, 
Japan
N= ,824 (aged 20-79 
years)
Prevalence – ATPIII criteria: men 14.2%,women 
17.7%.
Moderate exercise (2-3 sessions/week) and light 
alcohol drinking (<15 g/d) had inverse association 
with MetS.
[56]
Cross-sectional Oman N=1,419 adults (≥20 
years)
Age adjusted prevalence – ATPIII criteria: 21.0% 
(men 19.5%, women 23.0%; p=0.236).
[57]
Cross-sectional Australia N=5,850 of which 
4,060 had biochemical 
examination
Prevalence – IDF criteria: 22.8 (men 26.4%, women 
15.7%); ATPIII criteria: 15.0% (men 19.4%, 
women 14.4%).
[58]
Cross-sectional Greece N=9,699 adults Age adjusted prevalence – IDF criteria: 43.4%; 
ATPIII criteria: 24.5%.
Lower vascular risk in those with IDF defined MetS 
than with ATPIII defined (p<0.0001).
[59]
Cross-sectional Spain N=1,030 adults Age adjusted prevalence – WHO criteria: 28.0%; 
EGIR criteria: 15.9%; NCEP criteria: 23.0%; Revised 
NCEP criteria: 28.2%.
High prevalence of the syndrome irrespective of the 
criteria used.
[60]
Cross-sectional Venezuela N=3,108 men and women 
(≥20 years)
Prevalence – ATPIII criteria: men 31.2%, women 
24.1%.
Family history of diabetes, obesity, HT and 
sedentary lifestyle were positively associated with 
the MetS.
[61]
Cross-sectional U.S.A N=3,601 adults (>20 
years)
Prevalence – ATPIII criteria: 34.5% (men 33.7%, 
women 35.4%); IDF criteria: 39.0% (men 39.9%, 
women 38.1%).
[62]
Cross-sectional Japan N=8,144 individuals (19-
88 years)
Prevalence – ATPIII criteria: 19% men, 7% women.
Significantly more in men than women (OR=3.08).
HT was the most common component in all the 
individuals diagnosed with the syndrome.
[63]
Prospective Mexico N=2,282 (1990-1992), 
N=1,764 (1993-1995), 
N=1,754 (1997-1999)
Prevalence – ATPIII criteria: 38.9% (men 1990-
1992), 43.4% (men 1993-1995), 39.9% (men 
1997-1999); 65.4% (women 1990-1992), 65.7% 
(women 1993-1995), 59.9% (women 1997-1999).
No change in syndrome’s prevalence was observed 
in men (p=0.349) between 1990-1992 and 1997-
1999, but it decreased in women (p<0.001).
[64]
Cross-sectional China N=2,893 Prevalence – ATPIII criteria: 16.7%.
Age related increase in the prevalence from 3.1% 
(25-29 years) to 41.0% (>70 years).
[65]
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Design Country Sample Salient Finding(s) Reference
Prospective U.S.A N=6,436 men and women 
(≥20 years) from NHANES 
III (1988-1994) and 1,677 
participants from NHANES 
1999-2000
Age adjusted prevalence – ATPIII criteria: 24.1% 
(NHANESIII), 27.0% (NHANES 1999-2000); 
p=0.088.
Increase in prevalence was more among women 
(p=0.021) than men (p=0.831).
[66]
Prospective, 
Case-Control
U.S.A N=32,826 women (cases) 
and N=785 (controls)
Baseline levels of TNF, IL, and CRP were 
significantly higher in cases than controls (p≤0.001).
Significant association of CRP with risk of DM 
(OR:3.99, p<0.001).
[67]
Cross-sectional Finland N=2,049 adults (FINRISK 
study) aged 45-64 
years; N=522 adults of 
the Finnish Diabetes 
Prevention Study (DPS) 
with IGT
Prevalence modified WHO criteria FINRISK cohort: 
38.8% men, 22,2% women; DPS Cohort: 78,4% 
men, 72,2% women.
[68]
Cross-sectional Greenland N=917 adults Prevalence – WHO criteria: 20.7%; ATPIII 
criteria: 17.9%.
Moderate agreement between 2 definitions 
(κ=0.56).
[69]
Cross-sectional Tehran N=103,68 adults (4,397 
men and 5,971 women) 
aged 20 years and over
Prevalence: 33.7%, increased with age in both 
sexes.
MetS and its abnormalities were more common in 
women in comparison to men (p<0.001).
[70]
Cross-sectional U.S.A N=8,814 men and women 
(aged 20 years or older)
Prevalence – ATPIII criteria: 23.7%.
Age related increase in prevalence was seen from 
20 to 29 years and 60 to 69 years.
[23]
Cross-sectional Korea N=3,305 black, 3,477 
Mexican American, and 
5,581 white men and 
non-pregnant or lactating 
women (aged 20 years 
and older)
Prevalence – ATPIII criteria: 22.8% men, 22,6% 
women.
Mexican American ethnicity was more prone to 
develop MetS.
[71]
Cross-sectional Irish N=890 (aged 50-60 years) Combined prevalence according to WHO and 
ATPIII criteria: 13.1%.
Age related increase in prevalence was seen.
Moderate correlation between both criteria 
(κ=0.53, 0.46-0.60).
[72]
Table II. Prevalence of MetS according to Age, diagnostic criteria and Occupation
ATPIII = Adult Treatment Panel III; BMI = Body Mass Index; CRP = C Reactive protein; CVD = Cardiovascular 
Disease; DM = Diabetes Mellitus; EGIR = European Group for the study of Insulin Resistance; HT =Hypertension; 
IDF =International Diabetes Federation; IL = Interleukin; NCEP = National Cholesterol Education Program; 
NHANES = National Health and Nutrition Education Survey; TNF = Tumor Necrosis Factor; WHO = World Health 
Organization
Limitation nevertheless exists in the data published on the prevalence of MetS among adolescents 
and young adults. Estimates vary from 1% among adolescents in Japan (mean age-15 years), 6.4% in 
United States (12-19 years), 6.5% in Mexico (10-18 years) to10% in Iran (10-19 years) [10,45]. Young 
adulthood is marked by transition from the carefree adolescent phase to a more responsible phase 
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that brings along the pressure of finding new jobs and adjusting into them, coupled with changes in 
diet and lifestyle [73]. Though MetS portrays low prevalence among youth, clustering of risk factors 
can result in the progression towards the syndrome in adulthood, thus, advocating early identifi-
cation for alleviation of the problems related to the syndrome is essential [74,75]. This holds true 
especially, in the Indian context, as the prevalence of all the individual components of the syndrome 
is on the rise.
Causes and risk factors
MetS is a challenging condition due to its varying definitions, cut-offs, and limited data for certain po-
pulations especially the young adults and elderly. It is not a discrete entity but consists of multitude of 
risk factors. The risk varies in an individual depending on the aggregation of metabolic and non-meta-
bolic risk factors [13]. According to the AHA statement [13], atherogenic dyslipidemia, elevated blood 
pressure, and elevated plasma glucose are the most familiar risk factors. Abdominal obesity [71,76,77], 
insulin resistance [6,78], along with physical inactivity [71,79], aging [23], hormonal imbalance [80], 
and atherogenic diet (a diet rich in saturated fat and cholesterol) can exacerbate the risk for developing 
MetS, and consequently CVD [1]. Relationship of MetS with sex, age, degree of obesity and socio-
economic status has also been confirmed [81,82]. A solitary factor cannot purport to development of 
the syndrome; therefore, interaction amongst various domains relating to it, holds colossal worth that 
needs to be evaluated with the help of longitudinal studies [24].
Diet and metabolic syndrome: a complex relationship
Chronic diseases develop through a continuum from birth to adulthood with the interplay of genetics 
and environment. It has been gathered through the recent data that fetal/metabolic programming in 
utero due to poor maternal diet results in MetS, which is eventually responsible for all chronic diseases 
in future. Insulin resistance owing to thrifty genotype is the basic etiological factor leading to MetS. 
Though, the “Stone Age/Cave Man” diet of our hunter gatherer ancestors was far healthier from what 
we eat today; experience of alternate periods of abundance and scarcity during that time, led to an 
adaptive trait to survive the situation resulting in quick insulin release and lipid synthesis during star-
vation, to provide energy. However, with the advent of agriculture and urbanization, current diets have 
changed extremely from being healthy to those that are rich in saturated fat and cholesterol, which 
coupled with sedentary lifestyle leads to rapid glucose release and eventually positive energy balance. 
Whereas on one hand, thrifty genotype lead to increased survival chances with meager food supply, in 
times of abundant food availability it has led to development of chronic diseases and sedentary lifestyle 
[83]. Therefore, it emerges that faulty diet is a major root-cause of the problem and is the preventive 
measure that needs to be taken to ameliorate MetS or at least reduce its prevalence.
Effective dietary patterns
Mediterranean diet
A dietary pattern consisting of fruits, vegetables, whole grains, legumes, and fish, dairy products, wine 
and nuts in moderation is categorized as the Mediterranean Dietary pattern. When taken appropria-
tely and adhered to properly, it results in improvement of health and quality of life [84]. The efficacy of 
Mediterranean diet on MetS has been observed through many studies [85-89]. However, when the Me-
diterranean dietary pattern is not strongly adhered, there are no changes in the metabolic risk factors. 
Fruit, vegetables, cereals, whole fat dairy products, MUFA and moderate alcohol intake in the form of 
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red wine had a protective effect, while intake of red meat resulted in increased risk [90]. Similar results 
with respect to red meat were indicated in the Oxford EPIC cohort [91] with more than 11000 subjects 
aged 20-79 years, wherein, no consumption of meat, fish, eggs or dairy products resulted in decrement 
in the blood pressure levels by 2-4 mmHg compared to regular meat consumers.
Incidence in the reduction of MetS can be brought about with proper diet strategies incorporating the 
components of Mediterranean diet [92] such as adequate consumption of omega-3 fatty acids, reduc-
tion of saturated and trans fats, and high intake of fruits, vegetables, whole grains, and nuts (Table III). 
In a randomized control trial, the experimental group following a prudent dietary pattern over a period 
of 2 years in Naples (n=180) (Italy), resulted in reduction of 55.6% in prevalence of MetS compared 
to 13.3% reduction in the control group. A meta-analysis of 12 studies with more than 1.5 million in-
dividuals tracked for 3-18 years for their health and health habits [93] demonstrated the effectiveness 
of Mediterranean diet in age related morbidity conditions especially MetS, CVD (pooled relative risk 
0.91) and overall mortality (pooled relative risk 0.91), as has been proven over time94. Rumawas et al. 
[87] examined prospectively association between the Mediterranean-style dietary pattern and metabo-
lic syndrome in the Framingham Heart Study Offspring Cohort for 2730 participants, out of which 378 
diabetic patients and 318 patients reporting missing information were excluded, being followed up for 
7 years. Prudent dietary pattern – rich in whole grains, fruit, vegetables, nuts, and omega-3 fatty acids 
and low in refined grains and saturated and trans fats, has revealed to propose a substantial protection 
against heart disease.
Design Country Sample Salient Finding(s) Reference
RCT U.S.A Control: N=44 women 
(Mediterranean-style 
low-glycemic-load diet).
Intervention: N=45 
women (diet + medical 
food containing 
phytosterols, soy 
proteins)
Decreases in fat and sugar intake (p<0.001), and 
increase in DHA and EPA (p<0.001) were observed in 
both groups.
Significant reduction in all components of MetS (p<0.05) 
and plasma homocysteine levels was seen in the diet + 
medical food group (p<0.01) as compared to diet only 
group.
[86]
Prospective U.S.A N=2,730 adults Significantly lower incidence of MetS was seen among 
those following a Mediterranean style dietary pattern 
(p=0.01).
Mediterranean diet also led to significant lowering of 
waist circumference (p<0.001), fasting plasma glucose 
(p=0.03), and triglycerides (p<0.001) and higher HDL 
cholesterol (p=0.02).
[87]
RCT Iran N=100 obese 
adolescents (aged 12-
18 years)
Significant decrease in weight after 3 months of 
intervention (p<0.05) in the intervention group.
Significant decrease in BMI and increase in fruit and 
vegetable consumption was seen in the intervention 
group.
[88]
RCT Germany N=101 adults (N=48 
med diet group+100 
hrs of education vs 
N=53 written advice 
only group)
Increase in the consumption of fish, fruits/vegetables 
and moderately of canola/olive oil and increased plasma 
concentrations of long-chain n-3 polyunsaturated fatty 
acids.
No change in the markers of inflammation like hs-CRP, 
fibrinogen, fasting insulin, homocysteine, serum lipids 
and plasma fatty acids
[89]
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Design Country Sample Salient Finding(s) Reference
RCT Italy N=180 adults (99 men 
and 81 women) with 
MetS (ATPIII criteria)
Post 2 years significant increase in fruit, vegetables, 
whole grains, olive oil and nuts consumption (p<0.001), 
and decrease in mean body weight was observed in the 
intervention group (p<0.001).
Significant improvement in the endothelial function score 
(p<0.001) and reduction in the Hs-CRP values (p=0.01) 
and insulin resistance (p<0.001) was also observed in the 
intervention group
[90]
RCT Spain N=45 sedentary adults 
(50-66 years)
Significant weight loss and improvement in MetS 
components was achieved with hypocaloric, 
normoproteic Mediterranean diet (p < 0.05).
More significant weight loss was chieved with the 
combination of MeD and moderate intensity physical 
activity post 12 weeks compared to MeD alone (p<0.05)
[95]
Cross-sectional Spain N=578 adults 
(>18 years)
Prevalence – ATPIII criteria: 24.4%.
Red meat and vegetable intake were positively 
associated with syndrome.
Fruit intake, dairy products, moderate alcohol (red wine), 
cereals, and high MUFA: saturated fat demonstrated a 
protective effect.
[96]
Table III. Role of Mediterranean diet in the improvement of MetS
BMI = Body Mass Index; CRP = C Reactive Protein; DHA = Docosa Hexanoic Acid; EPA = Eicosa Pentanoic Acid; 
MeD = Mediterranean Diet; MUFA = Mono Unsaturated Fatty Acid
Specifically, each component of Mediterranean dietary pattern has its own significance that holds a key 
in obviating MetS. In the Bogalusa heart study, 1420 subjects aged 19-38 years were followed to make 
comparisons in the dietary intake of those who suffered from the syndrome with those who didn’t [97]. 
MetS was evident in 12% of the young population (NCEP ATPIII criteria). Dietary patterns revealed 
consumption of fruits, fruit juices, vegetables, low-fat dairy products, diet beverages, less sweetened be-
verages and alcohol among those with no risk factors. No relation was found for red meats or processed 
meats. Thus, poor fruit and vegetable consumption and high consumption of sweetened beverages can 
serve as independent risk factors for MetS.
The Mediterranean diet can be considered a function of the prudent dietary pattern; however, its rela-
tion with insulin resistance and metabolic risk factors for CVD in non-Mediterranean populations is 
largely unexplored. Another meta-analysis of 50 studies and 534,906 individuals to ascertain the effect 
of Mediterranean diet on MetS and its components has come up with findings from prospective studies, 
clinical trials as well as epidemiological trials, that it is beneficial in the reduction of the syndrome [98]. 
Therefore, Mediterranean diet as a function of the prudent dietary pattern has shown its beneficial ef-
fects in the improvement of MetS substantially as projected by the evidence gathered through the years.
Certain studies have demonstrated that high intake of saturated fatty acids [99-101] and low intake of 
n3 fatty acids [102] are responsible for MetS. Dairy products being a rich source of calcium have also 
shown to be beneficial in reducing the risk of blood pressure [103,104] MetS (Table IV), coronary heart 
disease [105], and inversely related to BMI. In a prospective study by Azadbakht et al. [106], it was 
seen that high intake of dairy was associated inversely with MetS, enlarged waist circumference and 
hypertension. The beneficial effect of the dairy products has been attributed by the presence of calcium 
in them that mediates the process of reducing the incidence of adiposity, hypertension and CVD, as 
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reported by various researchers [107-110]. Similar results with dairy calcium have been shown by Lin 
et al. [111]. They proposed that weight loss was more with dairy rich diets than calcium rich diets alone, 
which can also be due to the anti-obesity effect of protein in it [112]. A cross sectional study showed the 
same effect with calcium, however, some confounding factors such as physical activity, intake of fruits 
and vegetables were not taken into account [113]. In a 10 year long prospective study comparisons were 
made with respect to the amount of dairy intake and its ability to reduce the incidence of MetS [114]. 
However, similar causal reduction in the MetS incidence was not noticed in this study.
Year Design Sample Finding Reference
2009 Intervention N=153 obese adults with MetS 
randomised to intervention or 
control for 16 weeks
Significant improvement observed in body 
composition (p<0.01), physical and cardio-
metabolic fitness (p<0.01) with minimally 
prescriptive lifestyle intervention program.
[115]
2005 Cross-sectional N=827 subjects (357 men, 470 
women); 18-74 years
Inverse association of diary consumption 
with MetS (p<0.02), WC (p<0.001) and 
HT(p<0.02).
[106]
2005 Cross-sectional N=34 hyperlipidemic men and 
women
Reduction in CRP was observed with 
cholesterol lowering diet (p=0.001) and statins 
(p=0.013).
[116]
2005 Cross-sectional N=11,686 women; ≥45 years Mg intake was inversely associated with CRP 
(p<0.0001) and MetS (p=0.0008).
[117]
2003 NHANES survey 
(prospective)
N=17,030, 20 years or older 
both men and women
Higher Ca intake led to lower age-related 
increase in blood pressure (p<0.001).
[103]
2002 Cross-sectional N=192 individuals with MetS 
and 384 disorder-free control 
subjects, matched by age and 
gender
Inverse association between serum Mg levels 
and MetS (OR=6.8), dyslipidemia (OR=2.8) 
and high blood pressure (OR=1.9).
[118]
2002 Prospective N=3,157 black and white adults 
(18-30 years)
Inverse association of dairy products 
consumption with MetS in overweight adults 
(OR=0.79).
[114]
2003 Cross-sectional N=27,862 apparently healthy 
men and women (25-82 years)
Positive association of protein intake with BMI 
and weight gain/obesity.
[112]
2001 Prospective N=5,765 men (35-64 years) No association between milk consumption and 
CVD mortality.
[105]
2000 Cross-sectional N=7,543 men and 8,053 
women (25-69 years)
Negative association between Ca intake and 
blood pressure in both sexes (p<0.05).
[104]
2000 Prospective 
(RCT)
N=54 normal weight young 
women (18-31 years)
High Ca intake led to lower weight gain and 
body fat after 2 years of intervention.
[111]
2000 Cross-sectional N=2,537 women and 2,439 
men
Inverse association between dairy products and 
bread consumption and MetS in men.
[113]
1998 Cross-sectional N=180 postmenopausal women 
(45-64 years), and 197 men 
(30-64 years )
Both diet and exercise together led to decrease 
in the LDL levels after 1 year among women 
(p<0.05) and men (p<0.01).
[119]
Table IV. Relationship between dairy products and MetS
BMI = Body Mass Index; Ca = Calcium; CRP = C Reactive Protein; CVD = Cardiovascular Disease; 
HT = Hypertension; LDL = Low Density Lipoprotein; Mg = Magnesium; WC = Waist Circumference; 
MetS = Metabolic Syndrome
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Various epidemiological studies have suggested that magnesium can be an independent risk factor 
for the development of DMT2 [120-122], being a co-factor in number of enzymatic reactions that 
regulate glucose metabolism and insulin homeostasis [123,124]. In a cross-sectional study, an inverse 
association was reported between serum magnesium levels and MetS [118]; similar relationship was 
also seen with dietary magnesium intake [117]. In the CARDIA study, a total of 608 cases with MetS 
were identified in young adults (18-30 years; n=4637), wherein, magnesium intake was found to be 
inversely associated with it. Of particular significance, were the inverse associations of magnesium with 
blood pressure and triglycerides which were subsequently attenuated with lifestyle and dietary factors 
adjustment [51]. But the important question which arises is that, will a higher intake of magnesium 
prevent MetS? A question which can only be answered with more data from randomized control trials.
Vegetarian dietary pattern
The type of diet consumed also has various implications on MetS. A vegetarian diet consists of mostly 
food items that are from plants and plant products and does not have items resulting from death of ani-
mals. However, they may consume dairy products, milk and eggs [125]. The vegetarian dietary pattern 
can further be subdivided into lacto-ovo vegetarian (consuming milk, dairy products and eggs), lacto 
vegetarian (consuming milk and dairy products) and vegans (consuming no animal product). This ve-
getarian dietary pattern has shown to lower the risk of MetS. Rizzo et al. [126] studied various dietary 
patterns and looked at their association with MetS and its risk. Among subjects (n=773) of 30-94 years 
of age, dietary intake was assessed using a quantitative self-administered food frequency questionnaire 
and classified them into three categories – as vegetarian (consuming meat, poultry or fish <1 time in 
a month), semi-vegetarian (consuming fish at any frequency but other meats <1 time in a month), 
and non-vegetarians (consuming red meat or poultry ≥1 time/month). BMI was lowest in vegetarians 
and highest in non-vegetarians. MetS was classified according to the ATPIII criteria, with maximum 
number of components (i.e.5) for non-vegetarians. TG, FBG, BP, WC and BMI was significantly lower 
in vegetarians as compared to non-vegetarians (p<0.05). MetS was highest in non-vegetarians (39.7%), 
followed by semi-vegetarians (37.6%) and vegetarians (25.2%); with vegetarians having a lower odds 
for developing the syndrome (OR-0.44; p<0.001). Similar findings [127] were observed in case of male 
and female vegans and lacto-ovo vegetarians; with significantly lower BMI, TG level, TC/HDL ratio 
among vegans as compared to lacto-ovo vegetarians (p<0.05). Vegans also demonstrated more favora-
ble serum lipid profile as compared to lacto-ovo vegetarians.
De Baise et al. [128] tried to compare levels of TG, LDL-cholesterol and HDL-cholesterol between 
vegetarians (lacto-ovo vegetarians [n=19], lacto vegetarians [n=17] and vegans [n=18]) and omni-
vores (n=22). For the same, blood samples were drawn from 76 adults and it was observed that there 
was a significant difference for these biochemical parameter values among all groups except for HDL-
cholesterol. HDL/TC ratio was significantly higher in vegans (p<0.01), while TC and LDL-cholesterol 
values were highest for omnivores as compared to vegans (p<0.001). Cardiovascular risk [125] was also 
ascertained in a cohort of 201 individuals (35-64 years) in Brazil after classifying them as vegetarians 
(n=67) and omnivores (n=134). Levels of BP, FBG, TG, TC and LDL-cholesterol were significantly 
lower among vegetarians (p<0.001) except for HDL-cholesterol which showed no difference. Overall, 
vegetarians had a significantly lower cardiovascular risk (p<0.001) compared to omnivores whose diet 
consisted of animal protein and more fat.
Various studies related specifically to the Indian dietary pattern have shown risk for MetS and even-
tually CVD [129]. Whereas consumption of dairy foods, fried snacks and sweets consumption was 
associated positively with abdominal obesity; inverse relationship was observed with vegetables and 
pulses consumption for DM and hypertension. Vegetable and mustard oil consumption has also been 
proven beneficial [130]. The risk factors were more prevalent among the South Indians than North 
Indians [131].
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Other lifestyle risk factors
Alcohol
Moderate alcohol consumption exerts a protective effect on MetS. Specifically, red wine consumption 
(0.1-19.9 g/day) resulted in a two-fold decrease in the prevalence of high blood pressure among wo-
men compared to non-consumers [132]; and has also been shown to improve the CVD risk profile in 
a Spanish population based study [133]. In the National heart study and DESIR French study, higher 
HDL values were observed in alcohol consumers. The underlying mechanism of this protective effect is 
the direct effect that alcohol has on HDL cholesterol synthesis, by modifying the activity of lipoprotein 
lipase, hepatic lipase, and cholesterol-esterase [134].
Inverse association of HDL cholesterol, triglycerides and blood pressure with alcohol consumption has 
an impact on the MetS [134,135]. Alcohol consumption of less than 40 g/day for men and less than 20 
g/day for women suggested lower prevalence of MetS in comparison to non-alcoholics, as demonstra-
ted by a meta-analysis of seven observational studies136. Protective effect in wine drinking women 
(n=4232) with lower odds ratio of syndrome development (OR=0.60, p<0.05) has been seen compared 
to men in Sweden [137]. Opposing to this, are detrimental effects in case of heavy alcohol consumption 
such as increase in waist circumference, triacylglycerols, blood pressure, and glucose, thus, augmenting 
the risk of metabolic syndrome [135,138-140].
Smoking
Studies have indicated that smokers have a higher risk of becoming insulin resistant, hence, smo-
king can be considered as a modifiable risk factor for MetS [141,142]. In a cross-sectional study of 
3452 men, ≥20 years of age from a nationally representative sample of Koreans, a positive association 
between smoking and MetS was found [143]. Statistically significant association of current smoking 
amounts (p=0.023), total packs of cigarettes smoked during lifetime (p=0.040), with MetS, indicated 
smoking as an independent factor for the syndrome [144]. Evidence generated from different po-
pulation groups has also supported the relation of smoking with hypertension [145,146] and type 2 
diabetes [147,148].
With limited data on early identification of indicators of MetS before the development of the syndro-
me, a pilot study by Corwin et al. [149] estimated the risk scores in 41 subjects aged 18 to 39 years 
with 20 smokers and 21 non-smokers for three indicators: cardiovascular, metabolic, and immune 
related. Total risk scores were significantly greater in men (p=0.02) compared to women with only 
mixed effects of cigarette smoking. Similar effects of smoking on MetS have also been demonstrated 
by earlier studies [141,142,144]. Therefore, interventions focusing on modifiable risk factors should 
be undertaken.
Newer advancements
Oxidative stress
With still so many defining criteria for diagnosis of MetS, and an unclear picture on its pathophysio-
logy, there is still uncertainty about the concept of syndrome as a whole. It is characterized by altered 
antioxidant status and sub-clinical inflammation, and has shown association with oxidative stress [150]. 
Therefore, a combined condition of hyperglycemia and inflammation (both characteristics of MetS), 
leads to increased production of reactive oxygen species and eventually increased oxidative stress. The 
main reactive oxygen species generated is super oxide anion which is produced by NADPH oxidase 
[151]. Oxidative damage occurs as a result of enzymatic and non-enzymatic components (vitamins E 
and C), and in case of physiological conditions, cells exhibit anti-oxidative mechanism to counteract 
the damage. However, when there is increased production of reactive oxygen species, balance between 
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enzymatic and non-enzymatic components is disturbed leading to a pro-oxidative condition [150]. 
Specifically, in MetS, there is decrease in both enzymatic components as well as in the levels of vitamin 
C and E due to decreased total antioxidant status [151,152], which eventually leads to increased oxida-
tive stress proportionally [153]. Thus, has emerged the role of measurement of plasma oxidative stress 
which can identify MetS patients who are at an increased risk and those who may require intensive 
treatment.
Gut microbiota
Environment and epigenetics are two important factors that need to be considered in the origin of 
metabolic diseases as can be seen with gradual transition in eating habits, and increased consumption 
of fatty diets. However, it is still an unexplained concept as to why some people are sensitive and other 
resistant to metabolic disorders such as obesity and diabetes; therefore, individuality is an important 
concept that needs to be provided attention to. Therefore, four main factors emerge that are often 
overlooked in development of metabolic diseases-genetics, environment, individuality and rapid deve-
lopment of metabolic diseases. In this regard, role of intestinal and tissue microbiota is emerging that 
is linked to the development of metabolic diseases such as obesity and diabetes. The molecular mecha-
nism underlying hyperglycemia and increased body weight have been related to inappropriate energy 
expenditure. In case of T2DM, there is increased hepatic glucose production and decreased insulin 
action and secretion; whereas in case of obesity, there is actually decreased requirement of food intake 
and energy expenditure, so when that does not occur, molecular factors lead to adipose tissue deve-
lopment and body weight gain [154]. A newer concept explaining it describes that having a fatty meal 
triggers bacterial factors that cause modification in intestinal microbiota and enter the host through 
innate immune system, triggering inflammation [155]. These bacteria then go to metabolic tissues such 
as adipose tissue and liver. Inflammatory mediators impair insulin secretion and lead to more adipose 
tissue development. Therefore, treatment targeting at the right bacterial translocation for therapies or 
prevention of metabolic diseases is important. Various trials on mice have demonstrated the use of 
probiotics such as bifidobacterium lactis B420 in preventing insulin resistance [156].
Immune system and its changes lead to rapid increase in metabolic disorders; hence, it becomes all the 
more important to understand interaction between immune system and microbiota in order to know 
the underlying process in the development of metabolic diseases.
Early roots of Metabolic Syndrome: 
critical window of intervention
MetS has its roots early in life starting from the mother’s womb itself. Intrauterine growth has positive 
relationship with the syndrome’s occurrence. In the Atherosclerosis Risk in Young Adults (ARYA)-stu-
dy, 744 young adults aged 26-31 years, were tracked on their birth weight [157]. Findings of the study 
revealed that those who were in the lower tertile of birth weight (1,250-3,209 and 3,210-3,649 g) had 
1.8 times greater risk of developing MetS compared to those in the highest tertile (3,650-5,500 g). The 
syndrome is on the rise among young adults [158,159], with its roots embedded early in life [160-164]. 
A cohort of healthy young individuals in Amsterdam was followed for 24 years from the age of 13 years 
to 36 years to ascertain the prevalence of MetS (NCEP-ATPIII criteria) in relation to fatness, fitness 
and lifestyle. The prevalence was estimated as 10.4% (18.3% in men and 3.2% in women) at 36 years 
of age. Significant increases in the BMI and skinfold(s) ratio, compared to a significant decrease in the 
cardiopulmonary fitness was observed from adolescence to adulthood in adults with MetS, particularly 
at the ages of 21, 27, 32, and 36 years. Similar likelihood towards higher energy intake was observed 
throughout the years [165].
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Prevalence of the MetS is widespread in Asia, with India contributing 30% of it [30]. However, accor-
ding to the theory of developmental origin of health and disease, thrifty gene hypothesis is substantia-
ted to be the underlying factor for the syndrome [166]. The triad of low birth weight and stunting due 
to malnutrition in early life availability of energy-dense foods at a later age in life, and sedentary habits, 
eventually leading to obesity with alteration in the body composition in terms of fat deposition, insulin 
resistance, and diet related chronic diseases [83]. MetS continues to evolve over a period of lifetime as 
evident in case of Delhi birth cohort which indicated prevalence of CVD risk factors highest among 
the ages of 29-36 years [167]. Young adulthood is a critical period to target intervention strategies that 
prevent excess weight gain and central fat deposition. Public health interventions targeting young peo-
ple by focusing on the modifiable risk factors for the syndrome like weight control and regular physical 
activity can go a long way in restraining the development of DMT2 and CVD in future [165].
Conclusion
The problem of MetS is inevitable especially in a country like India, being a major public health chal-
lenge [83]. Given the magnitude of the problem, the public health responses should be strong, com-
mitted and focused both on primary and secondary prevention. Since, it is an emerging problem, the 
most important way of combating it, is to reduce its incidence by preventing its complications from 
developing. Prevention, by means of education – of both health professionals and public regarding 
healthy diet and lifestyle is required [168,169]. This will ensure minimization of health services cost to 
achieve maximum benefit to tackle this problem with available resources on a long term basis. Moreo-
ver, the rationale behind the therapeutic strategy for treatment of MetS highlights the fact that it is 
essential to correct insulin resistance, hyperinsulinimea and other metabolic abnormalities [170]. 
Therefore, the emphasis needs to be laid on comprehensive lifestyle change including both diet and 
physical activity; wherein, diet quality holds prime importance. Measurement of plasma oxidative 
stress and therapies targeting gut microbiota are current advancements in the field of MetS that are 
needed to be incorporated as strategies for early prevention of the syndrome. With long term mana-
gement and regular follow up, the lifetime risk of MetS can be substantially reduced [13]. The need of 
the hour is to create awareness among treating physicians as well as the people regarding early diagno-
sis and comprehensive treatment as well as prevention of all components of MetS in an “available, 
accessible and affordable” manner. Therefore, adoption of healthy diets such as the Mediterranean and 
vegetarian diet along with changes in lifestyle including regular physical activity and foregoing smo-
king and alcohol can be of utmost public health importance, as these changes are not only cost-effec-
tive for primary and secondary prevention of MetS, but feasible to implement by all population groups 
and various cultures.
Questions for further research
MetS is a complicated disorder that is increasing at an alarming rate. Prevention is the best way 
to reduce the incidence of the syndrome. Though studies have focused on modifying various risk 
factors such as diet, alcohol, smoking and physical activity; diet overweighs all the other factors in 
terms of its magnitude as well as its relationship with the syndrome. Future research needs to be 
carried out to identify newer dietary patterns or dietary modifications which have a potential to 
combat the syndrome. Newer techniques for identifying at-risk patients should also be developed 
which can go a long way in reducing the burden of disease as well as the increased healthcare 
costs that it imposes on the nations.
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